
Lydia Newsom, PharmD, discusses injection techniques, managing side effects, and the importance of collaboration between the healthcare team.

Lydia Newsom, PharmD, discusses injection techniques, managing side effects, and the importance of collaboration between the healthcare team.

As information changed rapidly, pharmacists quickly adapted their strategies by leveraging social media for updates to patients.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Drug Topics to discuss which indications patients typically gravitate toward for the use of GLP-1 medications.

Tom DePietro, PharmD, owner of DePietro's Pharmacy, highlights the deep community connections that enabled the pharmacy to respond effectively to the pandemic.

Kari Franson, PharmD, PhD, BCPP, senior associate dean for academic and student affairs and professor of clinical pharmacy at the University of Southern California, discusses the risk factors and considerations for cannabis use disorder.

Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.

Tom DePietro, PharmD, owner of DePietro's Pharmacy, highlights how their pharmacy leveraged social media, providing daily updates that were both educational and engaging.

Lauren Angelo, PharmD, associate dean for academic affairs at Rosalind Franklin University, explains common misconceptions and myths about vaccines.

Currently, there is no vaccine to prevent chlamydia, but treatment includes regimens of antibiotics, including doxycycline, azithromycin, and levofloxacin.

Kari Franson, PharmD, PhD, BCPP, senior associate dean for academic and student affairs and professor of clinical pharmacy at the University of Southern California, discusses the risks associated with cannabis use.

Jeffrey Bratberg, PharmD and Madi Hartling, a 2025 PharmD candidate, discuss the lack of pharmacists in medical shows and how pharmacists are typically portrayed negatively in media.

Lauren Angelo, PharmD, MBA, discussed current vaccination sentiments across the country and how misinformation has contributed to declining rates among US patients.

According to data science expert Don Roosan, PharmD, PhD, the capabilities of ChatGPT are just the beginning of what the future of artificial intelligence may look like in pharmacy practice.

Lindsey Miller, PharmD, clinical assistant professor of pharmacy practice at the University of Mississippi, discusses how pharmacists can help patients understand and effectively use continuous glucose monitoring.

Tom DePietro, PharmD, owner of DePietro's Pharmacy, discusses how his pharmacy served their community during the COVID-19 pandemic.

Lucas Berenbrok, PharmD, MS, discussed pharmacy deserts and how closures around the US have the potential to impact public health.

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists can implement an injectable contraception program.

Denosumab-bnht (Conexxence, Bomyntra) became the third biosimilar in 2025 to be approved for denosumab (Prolia, Xgeva).

Xyngari resulted in significant improvements in IGA treatment success, inflammatory lesion count, and non-inflammatory lesion count compared to placebo.

Kelly Goode, PharmD, BCPS, FAPhA, FCCP, professor in the department of pharmacotherapy and outcomes science at Virginia Commonwealth University, discusses the current landscape of immunization recommendations.

Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.

A conversation with Rob Frankil, RPh, executive director of the Philadelphia Association of Retail Druggists.

Jasmine Cutler, PharmD, CPh, assistant professor in the department of pharmacy practice at the Taneja College of Pharmacy, discusses role of education and accessibility in reproductive health.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, also addresses personalized care and the expanding responsibilities of pharmacists.

The decision makes the therapy the first oral antibiotic treatment approved for uUTIs in over 20 years.

Haley Pals, PharmD, BCPP, and Thomas Franko, PharmD, discussed the best approaches in the use of buprenorphine for treating patients with SUD.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, discusses recent advancements in diabetes care.

With the rise of large-language models like ChatGPT, pharmacists must know the potential challenges they may encounter when using these new technologies.

Lydia Newsom, PharmD, discusses how to support patients who are struggling with injection techniques or gastrointestinal side effects of GLP-1s.

In the evolving landscape of community pharmacy, the Prescription Shoppe emerged as a beacon of resilience and patient-centered care during the COVID-19 pandemic.